Center for Disease Control (CDC) and Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
OD/DPCPSI/OAR
|
The CDC / HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment shall advise the Secretary; the Director, CDC; and the Administrator and Associate Administrator for HIV/AIDS, HRSA, regarding objectives, strategies, policies, and priorities for HIV and STD/hepatitis prevention and treatment efforts including surveillance of HIV infection, AIDS, STDs/hepatitis, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS and STDs/hepatitis; identification of policy issues related to HIV/STD/hepatitis professional education, patient healthcare delivery, and prevention services; agency policies about prevention of HIV/AIDS and other STDs, treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV and STDs/hepatitis; and support to the agencies in their development of responses to emerging health needs related to HIV and other STDs/hepatitis.
|
Characterizations of Fungal Exposures
|
Research Initiative
|
CDC
|
NIEHS
|
These studies address the limitations in traditional methods for assessing fungal exposures by using molecular techniques to identify fungi in dust samples and biological fluids.
|
Characterize Emerging HIV Strains from Blood Donors and Patients
|
Research Initiative
|
FDA
|
NIAID
|
This initiative will characterize emerging HIV strains from blood donors and patients to determine viral tropism based on co-receptor usage strains. It will update the global viral panels to analyze multiple, diverse isolates from different parts of the world. This activity is part of NIAID’s ongoing efforts to develop a well-characterized repository for diagnostics, and drug and vaccine studies.
|
Chemical Integrated Program Team (IPT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NICHD
|
This workgroup is a Public Health Energy Enterprise. The IPT working group provides an end-to-end vision of medical countermeasures needed for a particular threat type (e.g., anthrax, rad/nuc, etc.). The scope of their work includes setting requirements for the stockpiling of Medical Countermeasures (MCMs), MCM delivery, and dispensing and monitoring MCM development. The IPTs also advise the Enterprise Executive Committee as to threat- or capability-specific MCM priorities for improving preparedness, to inform leadership consideration of cross-threat prioritizations and strategic goal setting.
|
CHEMM (Chemical Hazards Emergency Medical Management)
|
Resource Development
|
ATSDR, CDC, OS
|
NLM
|
This activity is to develop and maintain a comprehensive web resource and mobile app (in conjunction with the Wireless Information System for Emergency Responders [WISER]). Chemical Hazards Emergency Medical Management (CHEMM) is a tool designed to provide access to comprehensive sets of information about chemical hazards via a user-friendly interface.
|
Child Abuse and Neglect Working Group (CANWG)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, HRSA, SAMHSA
|
NICHD, CSR, NIAAA, NIDA, NIMH, NINDS, OD/DPCPSI/OBSSR
|
The NIH Child Abuse and Neglect Working Group (CANWG) was established in response to a recent directive by the House Committee on Appropriations, which requested that NIH report on current NIH efforts, accomplishments, and future plans for research on child abuse and neglect. The CANWG is co-chaired by program staff from NICHD and NIDA (formally NIMH). The working group is also a subcommittee of the Federal Interagency Workgroup on Child Abuse and Neglect.
|
Children''s HHS Interagency Leadership on Disasters (CHILD) Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NICHD
|
The purpose of this workgroup is to document HHS''s steps taken and provide recommendation for next steps regarding the care of children and pregnant women in the event of a disaster.
|
Children''s Mental Health: Surveillance of Mental Disorders Among Children in the United States (CDC MMWR Special Report)
|
Resource Development
|
CDC, HRSA, SAMHSA
|
NIMH
|
In 2012, The Centers for Disease Control and Prevention (CDC) initiated a special Morbidity and Mortality Weekly Report (MMWR) on child mental health surveillance. This report provides a comprehensive look at surveillance systems that collect data on mental health issues. The report summarizes information about ongoing federal surveillance systems that provide estimates of the prevalence of mental disorders and indicators of mental health among children living in the United States, and presents estimates of childhood mental disorders and indicators from these systems during 2005-2011.
|
Chronic Fatigue Syndrome Advisory Committee (CFSAC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
OD/DPCPSI/ORWH, CSR, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIDCR, NIDDK, NIEHS, NIMH, NINDS, NINR, NLM
|
The Chronic Fatigue Syndrome Advisory Committee (CFSAC) provides advice and recommendations to the Secretary of Health and Human Services via the Assistant Secretary for Health of the U.S. Department of Health and Human Services on issues related to chronic fatigue syndrome (CFS). These include: 1) factors affecting access and care for persons with CFS; 2) the science and definition of CFS; and 3) broader public health, clinical, research and educational issues related to CFS.
|
Chronic Fatigue Syndrome Advisory Committee (CFSAC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NINR, CSR, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIDCR, NIDDK, NIEHS, NIMH, NINDS, NLM, OD/DPCPSI/ORWH
|
The Chronic Fatigue Syndrome Advisory Committee (CFSAC) provides advice and recommendations to the Secretary of Health and Human Services via the Assistant Secretary for Health of the U.S. Department of Health and Human Services on issues related to chronic fatigue syndrome (CFS). These include: 1) factors affecting access and care for persons with CFS; 2) the science and definition of CFS; and 3) broader public health, clinical, research and educational issues related to CFS.
|